Photodynamic Therapy for Bilateral Subfoveal Choroidal Neovascularization Complicating Stargardt Macular Dystrophy

Abstract

Our case provides further evidence that repeated PDT may be used for the treatment of choroidal neovascular membrane complicating Stargardt disease without deleterious effects up to 4 years after treatment.

Clinical outcomes of treated macular neovascularisation secondary to inherited retinal diseases: a literature review

“…FFM is a late-onset phenotypically similar condition to Stargardt disease (SD) CNV associated with SD has required repeated PDT for either persistent leakage or recurrences on FA 64 86 87. Querques et al reported a patient with SD and CNV who was successfully treated with three consecutive monthly intravitreal injections of ranibizumab and no recurrence at 6 months 88.…”